These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Immunohistochemical localization of ganciclovir in the human retina. Park SS; Girard B; Font RL; Hauw JJ; Young LH Curr Eye Res; 1998 Jun; 17(6):663-7. PubMed ID: 9663857 [TBL] [Abstract][Full Text] [Related]
8. Endogenous bacterial endophthalmitis as a complication of intravenous therapy for cytomegalovirus retinopathy. Tufail A; Weisz JM; Holland GN Arch Ophthalmol; 1996 Jul; 114(7):879-80. PubMed ID: 8660177 [No Abstract] [Full Text] [Related]
9. High-dose (2000-microgram) intravitreous ganciclovir in the treatment of cytomegalovirus retinitis. Young S; Morlet N; Besen G; Wiley CA; Jones P; Gold J; Li Y; Freeman WR; Coroneo MT Ophthalmology; 1998 Aug; 105(8):1404-10. PubMed ID: 9709750 [TBL] [Abstract][Full Text] [Related]
10. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group. Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847 [TBL] [Abstract][Full Text] [Related]
11. Use of the ganciclovir implant in the treatment of recurrent cytomegalovirus retinitis. Marx JL; Kapusta MA; Patel SS; LaBree LD; Walonker F; Rao NA; Chong LP Arch Ophthalmol; 1996 Jul; 114(7):815-20. PubMed ID: 8660164 [TBL] [Abstract][Full Text] [Related]
13. Nonprogressive CMV retinitis in AIDS patients with protease inhibitors therapy for AIDS. Ortega-Larrocea G; Feregrino-Goyos M Ocul Immunol Inflamm; 1997 Dec; 5(4):279-82. PubMed ID: 9455745 [TBL] [Abstract][Full Text] [Related]
14. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir. Jabs DA Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191 [TBL] [Abstract][Full Text] [Related]
15. Retinal structural features of cytomegalovirus retinitis with acquired immunodeficiency syndrome: an adaptive optics imaging and optical coherence tomography study. Arichika S; Uji A; Yoshimura N Clin Exp Ophthalmol; 2016; 44(1):62-4. PubMed ID: 26148637 [No Abstract] [Full Text] [Related]
16. Genotypic analysis of cytomegalovirus retinitis poorly responsive to intravenous ganciclovir but responsive to the ganciclovir implant. Kuo IC; Imai Y; Shum C; Martin DF; Kuppermann BD; Margolis TP Am J Ophthalmol; 2003 Jan; 135(1):20-5. PubMed ID: 12504692 [TBL] [Abstract][Full Text] [Related]
17. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. Martin DF; Sierra-Madero J; Walmsley S; Wolitz RA; Macey K; Georgiou P; Robinson CA; Stempien MJ; N Engl J Med; 2002 Apr; 346(15):1119-26. PubMed ID: 11948271 [TBL] [Abstract][Full Text] [Related]
18. Treatment of cytomegalovirus retinitis in AIDS patients using intravitreal injections of highly concentrated ganciclovir. Baudouin C; Chassain C; Caujolle C; Gastaud P Ophthalmologica; 1996; 210(6):329-35. PubMed ID: 8887389 [TBL] [Abstract][Full Text] [Related]
19. Cystoid macular edema due to cytomegalovirus retinitis in a patient with acquired immune deficiency syndrome. Weinberg DV; Moorthy RS Retina; 1996; 16(4):343-4. PubMed ID: 8865398 [No Abstract] [Full Text] [Related]
20. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome. Guembel HO; Hofmann F; van Even G; Cinatl J; Makabe R Ger J Ophthalmol; 1996 Nov; 5(6):490-1. PubMed ID: 9479542 [No Abstract] [Full Text] [Related] [Next] [New Search]